Torque Therapeutics Inc   Report issue

For profit Phase 1
Founded: Cambridge MA United States (2015)
Status: Acquired by Repertoire Immune Medicines (2029)

Organization Overview

First Clinical Trial
2018
NCT03815682
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Torque Therapeutics | Torque Therapeutics Inc

Active Ingredients

Drugs in Phase 1 Trials (1)

trq15-01 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1